Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Buerger's disease]

K Furukawa1, Y Yao, S Ishimaru

  • 1Second Department of Surgery, Tokyo Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Diagnostic criteria and treatment for Buerger's disease are known, but its causes and triggers require further investigation. Understanding these factors is key to developing effective therapies beyond standard drug treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of an endothelin receptor antagonist in rats with cyclosporine-induced hypertension.

Hypertension (Dallas, Tex. : 1979)·1995
Same author

Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression.

Archives of biochemistry and biophysics·1995
Same author

Functional analysis of the threonine- and serine-rich Gp-I domain of glucoamylase I from Aspergillus awamori var. kawachi.

Applied and environmental microbiology·1995
Same author

Comparison of specific reactivity of monoclonal and polyclonal ABH reactive antibodies.

Nihon hoigaku zasshi = The Japanese journal of legal medicine·1992
Same author

A novel method for blood group typing with the aid of monoclonal antibody immobilized dyed microspheres.

Nihon hoigaku zasshi = The Japanese journal of legal medicine·1992
Same author

Leukotriene C4 D4 antagonist markedly reduced inflammation in a rat model of inflammatory bowel disease.

Gastroenterologia Japonica·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Vascular Medicine
  • Immunology
  • Genetics

Context:

  • Buerger's disease, a rare inflammatory condition affecting blood vessels, presents diagnostic and therapeutic challenges.
  • While established criteria exist, the precise etiology and exacerbating factors remain largely unknown.
  • Current understanding necessitates further research into the underlying mechanisms of the disease.

Purpose:

  • To highlight the need for continued research into the etiology and exacerbation factors of Buerger's disease.
  • To emphasize the importance of developing targeted therapeutic strategies aligned with disease pathology.
  • To discuss the role of both pharmacological and surgical interventions in managing Buerger's disease.

Summary:

  • Recent advancements have defined diagnostic criteria and therapeutic strategies for Buerger's disease.

Related Experiment Videos

  • Significant gaps remain in understanding the disease's etiology and factors that worsen the condition.
  • Further research is crucial for elucidating these unknown aspects and refining treatment approaches.
  • Drug therapy forms the cornerstone of treatment, but aggressive surgical options can also be highly effective.

    • Impact:

    • Improved understanding of Buerger's disease etiology can lead to novel preventative measures.
    • Development of tailored therapies will enhance patient outcomes and quality of life.
    • This research underscores the need for a multi-faceted treatment approach, combining medical and surgical interventions.